To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes

Treatments: Drug: insulin

Study type: Observational

Funder types: Industry

Identifiers

NCT01493388

INS-3914

U1111-1124-9862 (Other Identifier)

Details and patient eligibility

About

This study is conducted in Africa. The aim of this study is to estimate the percentage of children and adolescents below or equal to 15 years in Tunisia with acceptably controlled diabetes mellitus type 1.

Enrollment: 402 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Written informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol).
• Child or adolescent below or equal to 15 years with diabetes mellitus type 1
• Who has been undergoing treatment for diabetes for at least 6 months

Exclusion criteria

• Previous participation in this study.
• Current participation to a clinical trial

Trial design

402 participants in 1 patient group

A

Treatment:

Drug: insulin